Tyrosine 813 is a site of JAK2 autophosphorylation critical for activation of JAK2 by SH2-Bβ

Molecular and Cellular Biology

Volumn 24, Issue 10, 2004, Pages 4557-4570

  Kurzer, Jason H ^a   Argetsinger, Lawrence S ^a   Zhou, Yong Jie ^b   Kouadio, Jean Louis K ^a,c   O'Shea, John J ^b   Carter Su, Christin ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES   (United States)

^c UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARRIER PROTEIN; DNA; GROWTH HORMONE; JAK2 PROTEIN, HUMAN; JAK2 PROTEIN, MOUSE; JANUS KINASE 2; ONCOPROTEIN; PROTEIN TYROSINE KINASE; RECOMBINANT PROTEIN; SH2B PROTEIN, HUMAN; SH2BPSM1 PROTEIN, MOUSE; SIGNAL TRANSDUCING ADAPTOR PROTEIN; TYROSINE;

AMINO ACID SEQUENCE; ANIMAL; ARTICLE; BINDING SITE; CELL LINE; CELL STRAIN 3T3; CELL STRAIN COS1; CHEMISTRY; DRUG EFFECT; ENZYME ACTIVATION; GENETIC TRANSFECTION; GENETICS; HUMAN; METABOLISM; MOUSE; NUCLEOTIDE SEQUENCE; PHOSPHORYLATION; SITE DIRECTED MUTAGENESIS;

3T3 CELLS; ADAPTOR PROTEINS, SIGNAL TRANSDUCING; AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; BINDING SITES; CARRIER PROTEINS; CELL LINE; COS CELLS; DNA; ENZYME ACTIVATION; GROWTH HORMONE; HUMANS; JANUS KINASE 2; MICE; MUTAGENESIS, SITE-DIRECTED; PHOSPHORYLATION; PROTEIN-TYROSINE KINASES; PROTO-ONCOGENE PROTEINS; RECOMBINANT PROTEINS; TRANSFECTION; TYROSINE;

EID: 2442659839     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.24.10.4557-4570.2004     Document Type: Article

References (47)

1. Aaronson, D. S., and C. M. Horvath. 2002. A road map for those who know JAK-STAT. Science 296:1653-1655.
2. Ahmed, Z., B. J. Smith, K. Kotani, P. Wilden, and T. S. Pillay. 1999. APS, an adapter protein with a PH and SH2 domain, is a substrate for the insulin receptor kinase. Biochem. J. 341:665-668.
3. Argetsinger, L. S., G. S. Campbell, X. Yang, B. A. Witthuhn, O. Silvennoinen, J. N. Ihle, and C. Carter-Su. 1993. Identification of JAK2 as a growth hormone receptor-associated tyrosine kinase. Cell 74:237-244.
4. Argetsinger, L. S., J.-L. K. Kouadio, H. Steen, A. Stensballe, O. N. Jensen, and C. Carter-Su. Autophosphorylation on tyrosines 221 and 570 regulates its activity, Mol. Cell. Biol., in press.
5. Benekli, M., M. R. Baer, H. Baumann, and M. Wetzler. 2003. Signal transducer and activator of transcription proteins in leukemias. Blood 101:2940-2954.
6. Boyle, W. J., P. van der Geer, and T. Hunter. 1991. Phosphopeptide mapping and phosphamino acid analysis by two-dimensional separation on thin-layer cellulose plates. Methods Enzymol. 201:110-148.
7. Candotti, F., L. Notarangelo, R. Visconti, and J. O'Shea. 2002. Molecular aspects of primary immunodeficiencies: lessons from cytokine and other signaling pathways. J. Clin. Investig. 109:1261-1269.
8. Carpino, N., R. Kobayashi, H. Zang, Y. Takahashi, S. T. Jou, J. Feng, H. Nakajima, and J. N. Ihle. 2002. Identification, cDNA cloning, and targeted deletion of p70, a novel, ubiquitously expressed SH3 domain-containing protein. Mol. Cell. Biol. 22:7491-7500.
9. Chen, C., and H. Okayama. 1987. High-efficiency transformation of mammalian cells by plasmid DNA. Mol. Cell. Biol. 7:2745-2752.
10. Cheng, A., N. Uetani, P. D. Simoncic, V. P. Chaubey, A. Lee-Loy, C. J. McGlade, B. P. Kennedy, and M. L. Tremblay. 2002. Attenuation of leptin action and regulation of obesity by protein tyrosine phosphatase 1B. Dev. Cell 2:497-503.
11. Darnell, J. E., Jr. 1997. STATs and gene regulation. Science 277:1630-1635.
12. Diakonova, M., D. R. Gunter, J. Herrington, and C. Carter-Su. 2002. SH2-Bβ is a Rac-binding protein that regulates cell motility. J. Biol. Chem. 277:10669-10677.
13. Feng, J., B. A. Witthuhn, T. Matsuda, F. Kohlhuber, I. M. Kerr, and J. N. Ihle. 1997. Activation of Jak2 catalytic activity requires phosphorylation of Y1007 in the kinase activation loop. Mol. Cell. Biol. 17:2497-2501.
14. Frank, S. J., W. Yi, Y. Zhao, J. F. Goldsmith, G. Gilliland, J. Jiang, I. Sakai, and A. S. Kraft. 1995. Regions of the JAK2 tyrosine kinase required for coupling to the growth hormone receptor. J. Biol. Chem. 270:14776-14785.
15. Herrington, J., L. S. Smit, J. Schwartz, and C. Carter-Su. 2000. The role of STAT proteins in growth hormone signaling. Oncogene 19:2585-2597.
16. Hou, S. X., Z. Zheng, X. Chen, and N. Perrimon. 2002. The Jak/STAT pathway in model organisms: emerging roles in cell movement. Dev. Cell 3:765-778.
17. Ihle, J. N. 1996. Janus kinases in cytokine signalling. Philos. Trans. R. Soc. Lond. B Biol. Sci. 351:159-166.
18. Ihle, J. N. 1996. STATs: signal transducers and activators of transcription. Cell 84:331-334.
19. Ihle, J. N., and I. M. Kerr. 1995. Jaks and Stats in signaling by the cytokine receptor superfamily. Trends Genet. 11:69-74.
20. Johnston, J. A., M. Kawamura, R. A. Kirken, Y.-Q. Chen, T. B. Blake, K. Shibuya, J. R. Ortaldo, D. W. McVicar, and J. J. O'Shea. 1994. Phosphorylation and activation of the Jak-3 Janus kinase in response to interleukin-2. Nature 370:151-153.
21. Kong, M., C. S. Wang, and D. J. Donoghue. 2002. Interaction of fibroblast growth factor receptor 3 and the adapter protein SH2-B. J. Biol. Chem. 277:15962-15970.
22. Kotani, K., P. Wilden, and T. S. Pillay. 1998. SH2-Bα is an insulin-receptor adapter protein and substrate that interacts with the activation loop of the insulin-receptor kinase. Biochem. J. 335:103-109.
23. Lacronique, V., A. Boureux, V. D. Valle, H. Poirel, C. T. Quang, M. Mauchauffe, C. Berthou, M. Lessard, R. Berger, J. Ghysdael, and O. A. Bernard. 1997. A TEL-JAK2 fusion protein with constitutive kinase activity in human leukemia. Science 278:1309-1312.
24. Leonard, W. J., and J. J. O'Shea. 1998. Jaks and STATs: biological implications. Annu. Rev. Immunol. 16:293-322.
25. Mizuguchi, R., and M. Hatakeyama. 1998. Conditional activation of Janus kinase (JAK) confers factor independence upon interleukin-3-dependent cells. Essential role of Ras in JAK-triggered mitogenesis. J. Biol. Chem. 273:32297-32303.
26. Moodie, S. A., J. Alleman-Sposeto, and T. A. Gustafson. 1999. Identification of the APS protein as a novel insulin receptor substrate. J. Biol. Chem. 274:11186-11193.
27. Myers, M. P., J. N. Andersen, A. Cheng, M. L. Tremblay, C. M. Horvath, J. P. Parisien, A. Salmeen, D. Barford, and N. K. Tonks. 2001. TYK2 and JAK2 are substrates of protein-tyrosine phosphatase 1B. J. Biol. Chem. 276:47771-47774.
28. O'Brien, K. B., L. S. Argetsinger, M. Diakonova, and C. Carter-Su. 2003. YXXL motifs in SH2-Bβ are phosphorylated by JAK2, JAK1, and platelet-derived growth factor receptor and are required for membrane ruffling. J. Biol. Chem. 278:11970-11978.
29. O'Brien, K. B., J. J. O'Shea, and C. Carter-Su. 2002. SH2-B family members differentially regulate JAK family tyrosine kinases. J. Biol. Chem. 277:8673-8681.
30. Peeters, P., S. D. Raynaud, J. Cools, I. Wlodarska, J. Grosgeorge, P. Philip, F. Monpoux, L. Van Rompaey, M. Baens, H. Van den Berghe, and P. Marynen. 1997. Fusion of TEL, the ETS-variant gene 6 (ETV6), to the receptor-associated kinase JAK2 as a result of t(9;12) in a lymphoid and t(9;15;12) in a myeloid leukemia. Blood 90:2535-2540.
31. Qian, X., and D. D. Ginty. 2001. SH2-B and APS are multimeric adapters that augment TrkA signaling. Mol. Cell. Biol. 21:1613-1620.
32. Riedel, H., N. Yousaf, Y. Zhao, H. Dai, Y. Deng, and J. Wang. 2000. PSM, a mediator of PDGF-BB-, IGF-I-, and insulin-stimulated mitogenesis. Oncogene 19:39-50.
33. Rui, L., and C. Carter-Su. 1999. Identification of SH2-Bβ as a potent cytoplasmic activator of the tyrosine kinase Janus kinase 2. Proc. Natl. Acad. Sci. USA 96:7172-7177.
34. Rui, L., D. R. Gunter, J. Herrington, and C. Carter-Su. 2000. Differential binding to and regulation of JAK2 by the SH2 domain and N-terminal region of SH2-Bβ. Mol. Cell. Biol. 20:3168-3177.
35. Rui, L., L. S. Mathews, K. Hotta, T. A. Gustafson, and C. Carter-Su. 1997. Identification of SH2-Bβ as a substrate of the tyrosine kinase JAK2 involved in growth hormone signaling. Mol. Cell. Biol. 17:6633-6644.
36. Saharinen, P., K. Takaluoma, and O. Silvennoinen. 2000. Regulation of the Jak2 tyrosine kinase by its pseudokinase domain. Mol. Cell. Biol. 20:3387-3395.
37. Silvennoinen, O., B. Witthuhn, F. W. Quelle, J. L. Cleveland, T. Yi, and J. N. Ihle. 1993. Structure of the murine JAK2 protein-tyrosine kinase and its role in interleukin 3 signal transduction. Proc. Natl. Acad. Sci. USA 90:8429-8433.
38. Tschirch, E., B. K. Beattie, N. Dowman, C. Carter-Su, and D. L. Barber. 2000. The erythropoietin receptor recruits the adaptor protein SH2-Bβ to a region necessary for proliferation and differentiation. Blood 96:568a (Abstract.)
39. Wakioka, T., A. Sasaki, K. Mitsui, M. Yokouchi, A. Inoue, S. Komiya, and A. Yoshimura. 1999. APS, an adaptor protein containing pleckstrin homology (PH) and Src homology-2 (SH2) domains inhibits the JAK-STAT pathway in collaboration with c-Cbl. Leukemia 13:760-767.
40. Wang, J., and H. Riedel. 1998. Insulin-like growth factor-I receptor and insulin receptor association with a Src homology-2 domain-containing putative adapter. J. Biol. Chem. 273:3136-3139.
41. Witthuhn, B. A., F. W. Quelle, O. Silvennoinen, T. Yi, B. Tang, O. Miura, and J. N. Ihle. 1993. JAK2 associates with the erythropoietin receptor and is tyrosine phosphorylated and activated following stimulation with erythropoietin. Cell 74:227-236.
42. Xie, S., H. Lin, T. Sun, and R. B. Arlinghaus. 2002. Jak2 is involved in c-Myc induction by Bcr-Abl. Oncogene 21:7137-7146.
43. Xie, S., Y. Wang, J. Liu, T. Sun, M. B. Wilson, T. E. Smithgall, and R. B. Arlinghaus. 2001. Involvement of Jak2 tyrosine phosphorylation in Bcr-Abl transformation. Oncogene 20:6188-6195.
44. Yamauchi, T., K. Ueki, K. Tobe, H. Tamemoto, N. Sekine, M. Wada, M. Honjo, M. Takahashi, T. Takahashi, H. Hirai, T. Tsushima, Y. Akanuma, T. Fujita, I. Komuro, Y. Yazaki, and T. Kadowaki. 1998. Growth hormone-induced tyrosine phosphorylation of EGF receptor as an essential element leading to MAP kinase activation and gene expression. Endocr. J. 45:S27-S31.
45. Yasukawa, H., H. Misawa, H. Sakamoto, M. Masuhara, A. Sasaki, T. Wakioka, S. Ohtsuka, T. Imaizumi, T. Matsuda, J. N. Ihle, and A. Yoshimura. 1999. The JAK-binding protein JAB inhibits Janus tyrosine kinase activity through binding in the activation loop. EMBO J. 18:1309-1320.
46. Zhou, Y. J., M. Chen, N. A. Cusack, L. H. Kimmel, K. S. Magnuson, J. G. Boyd, W. Lin, J. L. Roberts, A. Lengi, R. H. Buckley, R. L. Geahlen, F. Candotti, M. Gadina, P. S. Changelian, and J. J. O'Shea. 2001. Unexpected effects of FERM domain mutations on catalytic activity of Jak3: structural implication for Janus kinases. Mol. Cell 8:959-969.
47. Zhou, Y. J., E. P. Hanson, Y. Q. Chen, K. Magnuson, M. Chen, P. G. Swann, R. L. Wange, P. S. Changelian, and J. J. O'Shea. 1997. Distinct tyrosine phosphorylation sites in JAK3 kinase domain positively and negatively regulate its enzymatic activity. Proc. Natl. Acad. Sci. USA 94:13850-13855.